The Studies · fact-check
Does hyperbaric oxygen reverse aging? What the telomere study actually showed
Hyperbaric oxygen therapy “reverses aging” by lengthening telomeres and clearing senescent cells.
A real, peer-reviewed signal at a clinical dose you cannot buy, in a tiny sample with no control arm for the telomere result, from a team with disclosed financial ties to a hyperbaric company. Intriguing, not settled, and not what a home chamber delivers.
What it actually found
Thirty-five healthy adults aged 64 and over enrolled, and 30 completed 60 hyperbaric sessions over three months at 2.0 ATA breathing pure oxygen; 25 had usable telomere samples. Telomere length in isolated immune cells rose by up to ~38% (in B cells), and senescent-cell counts fell by up to ~37%. A separate randomised arm of 63 people found improvements in attention and processing speed that tracked with cerebral blood flow.
On its face that is a striking result, and it is the single paper behind almost every "hyperbaric reverses aging" headline you have seen.
The caveats the headlines skip
The telomere result had no control group – it is a single-arm before-and-after in 35 enrolled people, 25 of them analysed, the weakest design for a claim this big. The cognition arm was properly randomised, but still small, short, and single-centre.
The paper discloses that its senior author, Shai Efrati, is a shareholder in AVIV Scientific and that three co-authors work for it; Aviv Clinics sells a hyperbaric program built on this research. That does not make the data wrong, but independent replication is thin, and a financial interest in the result is a reason for caution, not excitement.
Durability is unknown: no source establishes how long any effect lasts after the sessions stop.
What it means if you are buying a chamber
The dose that produced these numbers was 2.0 ATA on 100% oxygen, supervised, for 60 sessions. The soft-shell chambers sold for home use cap at 1.3 ATA on room air – a different, weaker intervention that this study did not test. Citing the 2.0 ATA telomere result to sell a 1.3 ATA home unit is the category’s central bait-and-switch.
If the science interests you, buy a course of clinic sessions at the studied dose, not a five-figure home chamber that cannot reach it. See our hyperbaric chamber cost guide for the rent-versus-buy math, and our purchases-to-skip guide for why the 1.3 ATA home unit is one of the buys worth delaying.
What we read
- Aging · Efrati et al. (2020)Telomere lengthening at 2.0 ATA across 60 sessions →
- Aging · Efrati et al. (2020)Cognition RCT in healthy adults 64+ →
- UHMSLow-pressure fabric chambers: cleared for acute mountain sickness only, air only →
- FDAReports of serious injuries and deaths with HBOT devices; safe-use recommendations (August 2025 letter) →
See the scored Hyperbaric chambers guide →
By David Persson · Updated 2026-10-22 · Corrections: hi@agewell.guide
